Form 8-K · Current report
American Express 8-K, filed Oct 23, 2026
- Filed
- CIK
- 0000004962
- Accession no.
- 0000004962-26-000405
Summary
American Express Company reported financial results for the third quarter of 2026 on October 23, 2026, filing the results with the SEC on Form 8-K under Items 2.02 and 7.01. The filing's exhibits include the earnings release and additional information on the quarter's results.
Key points
- The earnings release for the third quarter of 2026 is attached to the Form 8-K as Exhibit 99.1.
- Additional information on the third-quarter results is attached as Exhibit 99.2.
- The filing's forward-looking statements address management's 2026 guidance and potential impacts to 2027 guidance.
- Risks cited include credit performance, net card fee revenue, net interest income, rewards and marketing expenses, tariffs, interest rates, AI adoption and agentic technologies, and card-acceptance and fee regulation.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure The following information is furnished under Item 2.02 – Results of Operations and Financial Condition and Item 7.01 – Regulation FD Disclosure: On October 23, 2026, American Express Company (the “Company”) reported financial results for the third quarter of 2026. A copy of the Company’s earnings release is attached to this report as Exhibit 99.1 and additional information relating to the Company’s financial results for the third quarter of 2026 is attached to this report as Exhibit 99.2. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.